Our customer-focused philosophy has always been to continually integrate cutting-edge, imaging applications into daily clinical practice. With the SOMATOM Sensation 64, we continue this tradition and firmly establish a new industry benchmark for diagnostic excellence. A significant improvement in visualization of the finest details is what physicians expect from the latest CT technology: The SOMATOM Sensation 64 and its z-Sharp Technology perfectly meets this requirement, it allows you to take full advantage of unprecedented image quality, detail, and speed. Virtually every user can image the smallest pathology and finest anatomical structures in just a few seconds.

• More than 100 installations worldwide firmly establish a new industry benchmark for diagnostic excellence
• Unprecedented image quality and detail with the industry’s highest routine isotropic CT resolution of below 0.4 mm voxel size and complete spiral artifact elimination
• Highest Speed with the industry’s fastest CT rotation of 0.33 seconds

Seamless Workflow with Leading-edge clinical applications

SOMATOM Sensation provides you the widest range of clinically proven applications Siemens has to offer, enabling you to increase your diagnostic confidence while discovering additional clinical fields. This includes the triple rule out of acute chest pain or applications like syngo LungCARE or syngo Colonography that support the diagnostic process of a dedicated clinical problem – from the visualization and lesion evaluation to the clinical documentation. Additionally the SOMATOM Sensation offers you latest clinical applications ahead of time. One example, the Nodule Enhanced Viewing software package – the world’s first second reader tool for computer assisted, automatic display of suspicious pulmonary nodules.

The SOMATOM Sensation also enhances your clinical performance utilizing the newly developed Speed4D^TM Technology. It enables the automation of complex imaging processes and provides consistent, high quality results in a minimum amount of time.